Cannacord Genuity has just jncluded Daybue [as shown below] as 1 of 3 reasons for an overnight Acadia share price upgrade:
"an opportunity in Rett syndrome that we view as underappreciated by investors with Daybue stabilizing in the US and European approval possible in 1Q26".
Kens
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.10 |
Change
-0.100(0.70%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $14.23 | $14.71 | $14.03 | $681.6K | 47.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 373 | $14.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.15 | 64 | 1 |
View Market Depth
| Last trade - 10.10am 30/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |